Cargando…

Can we stop AIDS with antiretroviral-based treatment as prevention?

Challenges to scaling up treatment as prevention (TasP) of HIV transmission are considerable in the developing-world context and include accessing at-risk populations, human resource shortages, adherence and retention in care, access to newer treatments, measurement of treatment effects, and long-te...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Edward J, Nachega, Jean B, Ford, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168559/
https://www.ncbi.nlm.nih.gov/pubmed/25276515
http://dx.doi.org/10.9745/GHSP-D-12-00053
Descripción
Sumario:Challenges to scaling up treatment as prevention (TasP) of HIV transmission are considerable in the developing-world context and include accessing at-risk populations, human resource shortages, adherence and retention in care, access to newer treatments, measurement of treatment effects, and long-term sustainable funding. Optimism about ending AIDS needs to be tempered by the realities of the logistic challenges of strengthening health systems in countries most affected and by balancing TasP with overall combination prevention approaches.